FDA approval of eye implant to treat macular edema

Allergan, Inc. announced that the Food and Drug Administration approved the sale of its eye implant Ozurdex, intended to treat the vision disorder macular edema (swelling in the macula-area of retina responsible for quality vision) following blockage of retinal veins. The device is a biodegradable implant that is injected into the eye releasing a cortical steroid called dexamethasone improving vision.